The University of Hawaiʻi at Hilo is accepting applications for a new program that brings the Daniel K. Inouye College of ...
Marcus Flores, PharmD, BCPS, BCOP, discusses the vital role of pharmacists in multidisciplinary cancer care, exploring ...
Sophia Humphreys, PharmD, MHA, BCBBS, discusses common barriers to cancer therapy and how care teams can assist patients in ...
Impact: Immediate Savings to Requesting Rebates WATKINSVILLE, GA / ACCESS Newswire / October 28, 2025 / Rural hospitals in the 340B program are about to feel a new financial pressure. On January 1, ...
During the exclusive event, featuring Connect Biopharma’s CEO, Barry Quart, PharmD, attendees will gain insights into ... the nationally televised business program, announces that Synergy… ...
Verywell Health on MSN
4 Ways to Stop Magnesium Supplements From Making You Drowsy
One way to avoid daytime sleepiness is to take magnesium supplements earlier in the evening, so that a lower amount of magnesium will remain by the time you wake up.
To enhance and accelerate regulatory dialogue with the FDA To provide strategic guidance across clinical development programsTo bring deep expertise in CNS and immuno-oncology MADRID and CAMBRIDGE, ...
Certain vitamins, minerals, and healthy fats benefit brain health by supporting nerve function, protecting brain cells from damage, and improving focus.
Electra Therapeutics has completed an oversubscribed $183 million Series C financing it said will fund a global pivotal trial of its lead pipeline candidate, a frontline treatment for secondary ...
News-Medical.Net on MSN
Improving tobacco cessation care for people living with HIV
People living with HIV who smoke are currently more likely to die from lung cancer than from HIV-related causes. Two cancer ...
3don MSN
Research shows pharmacists can help people with cancer and diabetes better manage their blood sugar
People with cancer who received diabetes care from clinical pharmacists achieved significantly better blood sugar control, ...
Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company"), is a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections. It announced today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results